New molecular test predicts lung cancer survival better than staging
www.pulmccm.org
Non-small cell lung cancer (NSCLC) unfortunately recurs even more often than other cancers, even when early stage and apparently completely resected. The explanation, of course, is it wasn't completely resected: there was residual metastatic disease hiding out somewhere, but in such microscopic quantities as to be undetectable by our improving but still crude techniques (i.e., mediastinal lymph node survey and PET/CT scans).
New molecular test predicts lung cancer survival better than staging
New molecular test predicts lung cancer…
New molecular test predicts lung cancer survival better than staging
Non-small cell lung cancer (NSCLC) unfortunately recurs even more often than other cancers, even when early stage and apparently completely resected. The explanation, of course, is it wasn't completely resected: there was residual metastatic disease hiding out somewhere, but in such microscopic quantities as to be undetectable by our improving but still crude techniques (i.e., mediastinal lymph node survey and PET/CT scans).